Initial data from the Phase 1 trial expected in 2025 SAN FRANCISCO, CALIFORNIA, Jan. 27, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology ...
Kronos Advanced Technologies Inc. owns all common shares and maintains full voting control of KronosMD Inc. Additionally, KronosMD’s preferred shareholders collectively hold over 5,000,000 shares with ...
Dateline Season 28 Episode 9 investigates the murder of Pennsylvanian dentist John Yelenic, a death that shocked the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback